My understanding is that Lynparza is often used when someone has the BRCA gene. I read it was also used in certain other types of cancer as well.
March 30
Are you on Lynparza (olaparib) with a BRCA2 mutation?
Lynparza is a PARP inhibitor specifically approved for people with breast cancer who have BRCA1 or BRCA2 mutations. It works by preventing cancer cells from repairing themselves after being damaged by chemotherapy.
For BRCA-positive breast cancer, Lynparza may be used Show Full Answer
Are you on Lynparza (olaparib) with a BRCA2 mutation?
Lynparza is a PARP inhibitor specifically approved for people with breast cancer who have BRCA1 or BRCA2 mutations. It works by preventing cancer cells from repairing themselves after being damaged by chemotherapy.
For BRCA-positive breast cancer, Lynparza may be used:
- After adjuvant chemotherapy for early-stage disease (typically taken for one year)
- For metastatic (spread) breast cancer
- In combination with other treatments
Since you've been on it for two months with a BRCA2 mutation, you're receiving a treatment that's specifically designed to target your cancer's genetic profile. Studies suggest that adding Lynparza can help improve outcomes for people with BRCA mutations.
How are you managing with the medication so far? Many members find it helpful to share their experiences with side effects and tips for staying on track with treatment.
March 30
Join
Your Privacy Choices
